Jefferies Financial Group Inc. Illumina, Inc. Transaction History

Jefferies Financial Group Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.05 - $133.57 $2.78 Million - $3.67 Million	-27,510 Reduced 75.69%	8,838 $922,000
Q1 2024 May 13, 2024	BUY	$127.73 - $147.2 $4.27 Million - $4.92 Million	33,442 Added 1150.79%	36,348 $4.99 Million
Q4 2023 Feb 13, 2024	SELL	$92.79 - $142.53 $1.12 Million - $1.72 Million	-12,068 Reduced 80.59%	2,906 $404,000
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $989,255 - $1.48 Million	7,674 Added 105.12%	14,974 $2.06 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $421,889 - $535,141	2,300 Added 46.0%	7,300 $1.37 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $10.2 Million - $12.2 Million	-52,473 Reduced 91.3%	5,000 $1.16 Million
Q4 2022 Sep 21, 2023	BUY	$187.24 - $242.74 $9.39 Million - $12.2 Million	50,173 Added 687.3%	57,473 $11.6 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $10.8 Million - $14 Million	57,473 New	57,473 $11.6 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.